Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion late Monday. Inari stock catapulted on the news.

Large-bore mechanical thrombectomy scored a win over catheter-directed thrombolysis in patients with acute intermediate-risk pulmonary embolism. In the PEERLESS ... those treated with the FlowTriever ...

Stryker's acquisition of Inari for $4.9B enhances its neurovascular ... has not really been a player in venous markets like pulmonary embolism (or PE), deep vein thrombosis (or DVT), limb ischemia ...

About Inari Medical, Inc. and Integer Holdings Corporation Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical ... in the peripheral vasculature for treating pulmonary ...

About Inari Medical, Inc., iRhythm Technologies and Inc. Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy ... the peripheral vasculature for treating ...

Her sister rushed her to the hospital where doctors diagnosed her with a pulmonary embolism. Maria was treated with blood thinners which saved her life. A pulmonary embolism is a serious medical ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from William Blair analyst Margaret Kaczor today. The ...

Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old ... to patients undergoing catheter-directed treatment -- was cited as part ...